Avalon Pharmaceuticals to Present at Rodman & Renshaw 4th Annual Global Healthcare Conference
08 May 2007 - 9:30PM
PR Newswire (US)
GERMANTOWN, Md., May 8 /PRNewswire-FirstCall/ -- Avalon
Pharmaceuticals, Inc. (NASDAQ:AVRX), today announced that Kenneth
C. Carter, Ph.D., President and CEO, is scheduled to provide an
update on the Company at the Rodman & Renshaw 4th Annual Global
Healthcare Conference. The conference will be held on May 14-15,
2007 and Dr. Carter is scheduled to present on Monday, May 14, at
3:15 p.m. CEST (Central European Summer Time), 9:15 a.m. EDT
(Eastern Daylight Time). The presentation will be available live
via a webcast and can be accessed through the investor page of
Avalon Pharmaceuticals' website at: http://www.avalonrx.com/. An
archive of the presentation will be available for 30 days following
the conference. About Avalon Pharmaceuticals Avalon Pharmaceuticals
is a biopharmaceutical company using its proprietary technology,
AvalonRx(R), to discover and develop cancer therapeutics. Avalon
has a lead product in Phase I clinical development (AVN944 -- IMPDH
inhibitor), as well as preclinical programs to discover inhibitors
for the beta-catenin and aurora pathways now in late stage lead
candidate optimization. Avalon also has discovery programs on
modulators of survivin function and a drug discovery program
targeting the MYC oncoprotein, one of the most important and
previously intractable cancer targets. The company has value
generating partnerships with Merck, MedImmune, Medarex, and
Novartis. Avalon Pharmaceuticals was established in 1999 and is
headquartered in Germantown, Md. Contacts: Avalon Pharmaceuticals,
Inc. Russo Partners, LLC David D. Muth Wendy Lau (Media) Executive
Vice President & Tel: (212) 845-4272 Chief Business Officer
Tel: (301) 556-9900 The Trout Group LLC Fax: (301) 556-9910 Chad
Rubin (Investors) Email: Tel: (646) 378-2947 DATASOURCE: Avalon
Pharmaceuticals, Inc. CONTACT: David D. Muth, Avalon
Pharmaceuticals, Inc. Executive Vice President & Chief Business
Officer, +1-301-556-9900, fax, +1-301-556-9910, or ; or Media,
Wendy Lau of Russo Partners, LLC, +1-212-845- 4272, or Investors,
Chad Rubin of The Trout Group LLC, +1-646-378-2947, both for Avalon
Pharmaceuticals, Inc. Web site: http://www.avalonrx.com/
Copyright
Avalon (NASDAQ:AVRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Avalon (NASDAQ:AVRX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Avalon Pharmaceuticals (MM) (NASDAQ): 0 recent articles
More Avalon Pharmaceuticals (MM) News Articles